Brought to you by 
Spectranetics buys Kensey Nash's endovascular unit
03 Feb 2012
Executive Summary
Spectranetics (minimally invasive cardiovascular devices) has agreed to buy Kensey Nash's endovascular business unit for $10mm up front, plus earn-outs of up to $14mm ($8mm for product development and $6mm for cumulative sales of at least $20mm).
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Earnout
- Payment Includes Cash for Equity
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Spectranetics buys Kensey Nash's endovascular unit
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice